In a recent study, MD Analytics surveyed 300 physicians to gauge their awareness and use of AI, especially in light of the ChatGPT platform. The findings highlight a significant gap in AI understanding among healthcare professionals, with less than half familiar with the concept. Usage of AI, particularly language models like ChatGPT, remains low due to lack of familiarity and trust. Concerns include patient self-diagnosis based on AI-generated information and the resulting challenges for physicians. Bridging this knowledge gap is crucial to maximize AI’s potential in healthcare.
Daniel Turner, VP Client Services
Healthcare staff shortages hindering delivery of optimal patient care
The COVID-19 pandemic has undeniably impacted our healthcare system in many ways. One of the most significant impacts has been staffing shortages among Canadian healthcare workers.
Since the start of the pandemic there has been a substantial rise in shortages of healthcare workers across Canada. To what extent does this shortage affect physicians and their practice? How severe has the staffing shortage been in the past year? What type of support do physicians seek in order to reduce the workloads in their practice? To answer these questions MD Analytics surveyed 50 family medicine physicians and 90 specialists on the topic of healthcare staffing shortages across Canada, post pandemic.
Physician burnout leading many to reduce workload
For most of the general population, the pandemic is starting to feel like it’s a thing of the past. However, while most of us have found a sense of normalcy within our lives, the healthcare system is still reeling from its effects thereby impacting healthcare workers within it. What is the impact on Canadian physicians? What are the current consequences of the pandemic on their personal and professional lives? More specifically, how does this all impact the management of their workload? MD Analytics surveyed 50 family medicine physicians and 90 specialists on the topic of their professional and mental state 3 years after the onset of the pandemic.
Are remote consults here to stay?
With COVID-19 about to enter its 3rd year, it continues to significantly impact the lives of Canadians and the practices of HCPs in the country. Even though it has not been easy, physicians have continuously adapted how they manage their patients and how they interact with key healthcare stakeholders during the pandemic. MD Analytics has been monitoring these trends over the past few years and we have recently interviewed 140 physicians in our latest survey on the topic.
How Patient Support Program Providers Adjusted To The Pandemic
Physicians feel positive about how Patient Support Programs (PSPs) have evolved in the past two years – especially in terms of responsiveness and the expertise of individuals working on PSPs. The main unmet needs at this time remain the range of service hours and the availabilityof nurses remotely (either by phone or virtually). Many specialists believe that biosimilar PSP providers have struggled more than originator drug PSPs since the onset of the pandemic – mainly because of they do not have as many employees and offer a smaller range of services.
COVID-19 Impact on Patient Support Programs
Patient Support Programs (PSPs) play a significant role in ensuring that patients have the best possible experience during their journey – especially in specialty therapeutic areas where treatments tend to be more expensive. The COVID-19 pandemic has made it more challenging for patients to access support and services for their medical conditions. This has put additional pressure on company-sponsored PSPs to further enhance their offerings to help patients in the best way possible. PSPs have become increasingly important for patients since the onset of the COVID-19 pandemic and as a result now have an even more significant influence on physicians’ treatment selection process.
Pandemic’s Impact on HCPs Practices and Vaccination Campaign Perceptions
The COVID-19 vaccination campaign is underway in Canada. However, the pandemic has significantly altered HCPs’ practices to date. These changes have impacted workloads, patient assessments, and interactions with pharma. A year into the pandemic, a national COVID-19 vaccination campaign is underway. This begs the question, how are Canadian HCPs doing today? What do they foresee moving forward? Our latest short survey presents the current state of HCPs’ practices in Canada and their assessment of the government’s management of COVID-19.
Quelles sont les conférences auxquelles les médecins sont le plus susceptibles d’assister par voie numérique plutôt qu’en personne en 2021?
Les conférences médicales virtuelles sont en plein essor, mais sont-elles appelées à durer?
En raison de la pandémie survenue l’année dernière, les organisateurs de conférences et les marques de produits médicaux ont dû se précipiter pour trouver une solution afin de limiter les annulations d’importantes conférences médicales. Les plateformes virtuelles qui en ont résulté ont rapidement progressé pour reproduire l’expérience des conférences en personne par des moyens numériques. Si de nombreuses conférences médicales virtuelles ont été couronnées de succès, en termes de forte participation à de nombreux événements importants, tant nationaux qu’internationaux, des questions subsistaient quant à leur capacité à répondre aux besoins des médecins, des autres prestataires de soins de santé et des entreprises pharmaceutiques et de matériel médical qui parrainaient ces événements.
Virtual Medical Conferences – Promoting your brand to a digital audience
Virtual medical conferences are on the rise, but are they here to stay?
As a result of the pandemic over the past year, conference organizers and medical brands were set scrambling to find a solution to limit cancelations of key medical conferences. Resulting virtual platforms advanced quickly to emulate the face-to-face conference experience through a digital means. While many virtual medical conferences were successful, in terms of strong participation levels to many key events both national and international, questions remained as to how well they met the needs of physicians, other healthcare providers and the pharmaceutical and medical device companies sponsoring these events.
Will the Impact of COVID-19 on Physicians’ Practices Become the New Normal?
The COVID-19 crisis has significantly impacted physicians’ practices; but how and to what extent? Physicians have been managing significant workloads, while learning on the fly how to navigate and setup virtual meetings. Maintaining high levels of patient care while minimizing in-person interactions has also been challenging.
Forecasting New Pharma Products – Improving accuracy
Physicians recognize that new medications often can be quite valuable for their patients and are eager to add them to their armamentarium. However, they do not always end up prescribing these new medications as much as they initially plan or as early as they would like. There are many reasons that can explain this discrepancy.
Physicians’ Perspectives on Pitfalls in the Patient Journey
In the healthcare system, a patient’s journey to optimal care presents many obstacles. There are numerous steps involved from the onset of a medical condition to the moment when satisfactory results are achieved. This healthcare survey seeks to reveal key opportunities within the patient journey that would assist patients along their way and ultimately improve outcomes. Further healthcare market research could also be conducted by disease area to dig deeper into these insights.
Biosimilar Use in Cancer Treatment – Current attitudes and perceptions
Biological drugs, protein-based products derived from living cells using biotechnology, have been used since the 1990’s as a treatment option for cancer patients. Since 2009, biosimilar therapies (therapeutically equivalent subsequent entry biologics) have been available in different therapeutic areas in Canada, and are now on the verge of becoming available for use in oncology.
Oncologists’ Usage of Biomarker Testing is Growing, but Opportunities for Increased Use Remain
Biomarkers are molecules found in bodily fluids or tissues (including the tumor tissue). They provide valuable information about the cancer cells and non-cancer cells when analyzing which biomarkers are produced in response to the cancer. By developing a biomarker profile of a patient’s cancer, doctors can recommend the best suited treatment plan for their patient.
Smart Drugs – Attitudes and public health implications
Smart Drugs (or nootropics) are substances used to enhance cognitive functions. Exact usage numbers are difficult to ascertain, but a recent study conducted among UBC students found that 1 in 30 students admitted using ADHD medication they were not prescribed, for their cognitive effects. The use of Smart Drugs appears to be gaining momentum in Canada, especially among students and young professionals in high pressure situations, thereby having the potential to turn into a public health issue.